Sequential versus standard triple therapy for Helicobacter pylori eradication (Q24236178)

1

0 references

Adrian G McNicholl

2

0 references

Vincenzo Savarino

4

0 references

Giuseppina Oderda

5

0 references

Carlo Fallone

6

0 references

Lori Fischbach

7

0 references

Franco Bazzoli

8

0 references

Javier P Gisbert

Cochrane Database of Systematic Reviews

9

0 references

publication date

16 March 2011

0 references

published in

0 references

cites work

Meta-analysis, Simpson's paradox, and the number needed to treat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Simpson's paradox and calculation of number needed to treat from meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Evolution of Helicobacter pylori therapy from a meta-analytical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Sequential regimens for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Pooling data for number needed to treat: no problems for apples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

High Helicobacter pylori numbers are associated with low eradication rate after triple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Rating methodological quality: toward improved assessment and investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Seven-day therapy for Helicobacter pylori in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

7 January 2021

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

7 January 2021

A report card to grade Helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

7 January 2021

Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

7 January 2021

Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

7 January 2021

Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009034

7 January 2021